Public Citizen is calling on HHS Secretary Xavier Becerra to reduce the cost of weight-loss drugs Ozempic and Wegovy by using a rarely invoked statute to compel brand manufacturers to license their patents to the government, which could then allow generic manufacturers to produce and supply these drugs to federal health programs. According to Public Citizen, generics manufacturers have already submitted applications for semaglutide approval with FDA. In recent reports, state leaders and lawmakers have said the high prices of...